期刊文献+

Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer 被引量:5

Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer
下载PDF
导出
摘要 Systemic chemotherapy has enabled prolongation of survival in patients with stage IV colorectal cancer. This has subsequently increased the relative significance of local therapy for patients with oligometastases because they can be cured by removal of oligometastatic lesions. One of the most frequently reported tumor histologies for oligometastases is colorectal cancer. Resection is the standard therapy in most settings of oligometastases. Recently, studies have shown that stereotactic body radiotherapy (SBRT) may become a treatment option that provides high local control with minimal morbidity. Two-year local control rates following SBRT for hepatic and pulmonary oligometastases are almost over 80% and are even higher for patients treated with high-dose regimens. The indications of SBRT for other metastatic sites or conditions include isolated lymph nodes, spinal and adrenal metastasis, and post-surgical pelvic recurrence. Many retrospective studies have indicated that SBRT for various lesions results in good outcomes with low morbidity, both in the curative and palliative setting. However, few reports with a high level of evidence have indicated the efficacy of SBRT compared to standard therapy. Hereafter, the optimal indication of SBRT needs to be prospectively investigated to obtain convincing evidence. Systemic chemotherapy has enabled prolongation of survival in patients with stageⅣcolorectal cancer.This has subsequently increased the relative significance of local therapy for patients with oligometastases because they can be cured by removal of oligometastatic lesions.One of the most frequently reported tumor histologies for oligometastases is colorectal cancer.Resection is the standard therapy in most settings of oligometastases.Recently,studies have shown that stereotactic body radiotherapy(SBRT)may become a treatment option that provides high local control with minimal morbidity.Two-year local control rates following SBRT for hepatic and pulmonary oligometastases are almost over 80%and are even higher for patients treated with high-dose regimens.The indications of SBRT for other metastatic sites or conditions include isolated lymph nodes,spinal and adrenal metastasis,and post-surgical pelvic recurrence.Many retrospective studies have indicated that SBRT for various lesions results in good outcomes with low morbidity,both in the curative and palliative setting.However,few reports with a high level of evidence have indicated the efficacy of SBRT compared to standard therapy.Hereafter,the optimal indication of SBRT needs to be prospectively investigated to obtain convincing evidence.
出处 《World Journal of Gastroenterology》 SCIE CAS 2014年第15期4220-4229,共10页 世界胃肠病学杂志(英文版)
关键词 Oligometastasis Colorectal cancer Radiation therapy Stereotactic ablation body radiation therapy Local therapy Oligometastasis Colorectal cancer Radiation therap
  • 相关文献

参考文献13

  • 1Yun-Zi Wu Bin Li Tao Wang Shuang-Jia Wang Yan-Ming Zhou.Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis:A meta-analysis[J].World Journal of Gastroenterology,2011,17(36):4143-4148. 被引量:12
  • 2Hao Wang, Xian-Zhao Wei, Chuan-Gang FU, Fu-Ao Cao, Rong-Hua Zhao.Patterns of lymph node metastasis are different in colon and rectal carcinomas[J].World Journal of Gastroenterology,2010,16(42):5375-5379. 被引量:11
  • 3Mi-Sook Kim,Chul Koo Cho,Kwang Mo Yang,Dong Han Lee,Sun Mi Moon,Young Joo Shin.Stereotactic body radiotherapy for isolated paraaortic lymph node recurrence from colorectal cancer[J].World Journal of Gastroenterology,2009,15(48):6091-6095. 被引量:4
  • 4Arjun Sahgal,Eshetu G. Atenafu,Sam Chao,Ameen Al-Omair,Nicholas Boehling,Ehsan H. Balagamwala,Marcelo Cunha,Isabelle Thibault,Lilyana Angelov,Paul Brown,John Suh,Laurence D. Rhines,Michael G. Fehlings,Eric Chang.Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: A Multi-Institutional Analysis With a Focus on Radiation Dose and the Spinal Instability Neoplastic Score[J].Journal of Clinical Oncology.2013(27)
  • 5Joachim Widder,Theo J. Klinkenberg,Jan F. Ubbels,Erwin M. Wiegman,Harry J.M. Groen,Johannes A. Langendijk.Pulmonary oligometastases: Metastasectomy or stereotactic ablative radiotherapy?<!-- Pulmonary oligometastases -->[J].Radiotherapy and Oncology.2013
  • 6Roel C.J. Schlijper,Janneke P.C. Grutters,Ruud Houben,Anne-Marie C. Dingemans,Joachim E. Wildberger,Dirk Van Raemdonck,Eric Van Cutsem,Karin Haustermans,Guido Lammering,Philippe Lambin,Dirk De Ruysscher.What to choose as radical local treatment for lung metastases from colo-rectal cancer: Surgery or radiofrequency ablation?[J].Cancer Treatment Reviews.2013
  • 7T. Inoue,R.-J. Oh,H. Shiomi,N. Masai,H. Miura.Stereotactic body radiotherapy for pulmonary metastases[J].Strahlentherapie und Onkologie.2013(4)
  • 8Michel Gonzalez,Antoine Poncet,Christophe Combescure,John Robert,Hans Beat Ris,Pascal Gervaz.Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis[J].Annals of Surgical Oncology.2013(2)
  • 9Frank J. Lagerwaard,Neil K. Aaronson,Chad M. Gundy,Cornelis J.A. Haasbeek,Ben J. Slotman,Suresh Senan.Patient-Reported Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer[J].Journal of Thoracic Oncology.2012(7)
  • 10Tetsuya Inoue,Norio Katoh,Rikiya Onimaru,Hiroki Shirato,Yuzuru Niibe.Clinical Outcomes of Stereotactic Body Radiotherapy for Patients with Lung Tumors in the State of Oligo-Recurrence[J].Pulmonary Medicine.2012

二级参考文献19

  • 1吕明德,匡铭,梁力建,谢晓燕,彭宝岗,刘广健,黎东明,赖佳明,李绍强.手术切除和经皮热消融治疗早期肝癌的随机对照临床研究[J].中华医学杂志,2006,86(12):801-805. 被引量:102
  • 2Biasco G, Derenzini E, Grazi G, Ercolani G, Ravaioli M, Pantaleo MA, Brandi G. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties. Cancer Treat Rev 2006; 32: 214-228.
  • 3Saltz LB. Metastatic colorectal cancer: is there one standard approach? Oncology (Williston Park) 2005; 19: 1147-1154; discussion 1154, 1157-1158, 1160.
  • 4Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352: 476-487.
  • 5Singh AK, Grigsby PW, Rader JS, Mutch DG, Powell MA. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. Int J Radiat Oncol Biol Phys 2005; 61: 450-455.
  • 6Chou HH, Wang CC, Lai CH, Hong JH, Ng KK, Chang TC, Tseng CJ, Tsai CS, Chang JT. Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. Int J Radiat Oncol Biol Phys 2001; 51: 442-448.
  • 7Kim JS, Kim JS, Kim SY, Kim KH, Cho MJ. Hyperfractionated radiotherapy with concurrent chemotherapy for para-aortic lymph node recurrence in carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2003; 55: 1247-1253.
  • 8Kim MS, Choi C, Yoo S, Cho C, Seo Y, Ji Y, Lee D, Hwang D, Moon S, Kim MS, Kang H. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma. Jpn J Clin Oncol 2008; 38: 695-700.
  • 9Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
  • 10Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-1346.

共引文献32

同被引文献22

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部